Biomea Fusion (BMEA) Other Operating Expenses (2025 - 2026)
Biomea Fusion (BMEA) posted Other Operating Expenses of $510000.0 for Q1 2026, down 76.87% sequentially from $2.2 million in Q3 2025.
Biomea Fusion (BMEA) Other Operating Expenses (2025 - 2026) Analysis & Trends
Biomea Fusion has reported Other Operating Expenses for 2 years, with the latest figure at $510000.0 in Q1 2026.
- Quarterly Other Operating Expenses changed N/A year-over-year to $510000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.7 million (changed N/A YoY) and the FY2025 annual result came in at $2.2 million, changed N/A from the prior year.
- Other Operating Expenses declined to $510000.0 in Q1 2026 per BMEA's latest filing, from $2.2 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $2.2 million in Q3 2025 and troughed at $510000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Biomea Fusion | 97.69 Mn | 97.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 510,000.00 |
| Sep 30, 2025 | 2.21 Mn |